MedPath

EBG MedAustron GmbH

🇦🇹Austria
Ownership
-
Employees
-
Market Cap
-
Website

Radiotherapy Treatment Planning Comparison Using SBRT-PATHY (Photons) Versus CARBON-PATHY for Unresectable Bulky Tumors

Withdrawn
Conditions
Cancer
Interventions
Other: Planning CT, MRI
First Posted Date
2024-04-30
Last Posted Date
2025-05-11
Lead Sponsor
EBG MedAustron GmbH
Target Recruit Count
20
Registration Number
NCT06390657
Locations
🇦🇹

EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria

Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial)

Not Applicable
Recruiting
Conditions
Pancreas Cancer
Interventions
Radiation: Particle-therapy using protons or carbon ions
Diagnostic Test: Blood sampling
Diagnostic Test: Magnetic resonance imaging
Diagnostic Test: Computertomography
Diagnostic Test: 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)
First Posted Date
2022-01-14
Last Posted Date
2025-05-08
Lead Sponsor
EBG MedAustron GmbH
Target Recruit Count
30
Registration Number
NCT05191940
Locations
🇦🇹

EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer

Not Applicable
Recruiting
Conditions
Pancreatic Cancer
Proton Therapy
Interventions
Radiation: Proton Ions
Procedure: Surgical resection of the pancreas (when feasible)
First Posted Date
2021-05-20
Last Posted Date
2025-05-08
Lead Sponsor
EBG MedAustron GmbH
Target Recruit Count
10
Registration Number
NCT04894643
Locations
🇦🇹

EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria

🇦🇹

Department of Surgery, LK Wiener Neustadt, Wiener Neustadt, Austria

Particle-based Partial Tumor Irradiation of Unresectable Bulky Tumors

Not Applicable
Terminated
Conditions
Cancer
Interventions
Radiation: Particle radiotherapy
Diagnostic Test: Magnetic resonance imaging
Diagnostic Test: Computertomography
Diagnostic Test: Copper-64-Diacetyl-bis (N4-methylthiosemicarbazone) Positron Emission Tomography-Computer Tomography (64Cu-ATSM-PET-CT)
Diagnostic Test: 18-F-FluorDesoxyGlukose Positron Emission Tomography-Computer Tomography (18F-FDG-PET-CT)
Diagnostic Test: Blood sampling
First Posted Date
2021-05-06
Last Posted Date
2025-05-11
Lead Sponsor
EBG MedAustron GmbH
Target Recruit Count
13
Registration Number
NCT04875871
Locations
🇦🇹

EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria

Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer

Not Applicable
Terminated
Conditions
Intermediate Risk Prostate Cancer
Low Risk Prostate Cancer
Interventions
Other: EPIC questionnaire
Radiation: kV x-ray images
Radiation: Conebeam CT
First Posted Date
2018-11-14
Last Posted Date
2025-05-11
Lead Sponsor
EBG MedAustron GmbH
Target Recruit Count
5
Registration Number
NCT03740191
Locations
🇦🇹

EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria

Ion Therapy Patient Registry

Recruiting
Conditions
Ion Beam Radiation Therapy for Tumor Patients
Interventions
Radiation: Protons and Carbon Ions
First Posted Date
2017-02-09
Last Posted Date
2025-05-11
Lead Sponsor
EBG MedAustron GmbH
Target Recruit Count
2100
Registration Number
NCT03049072
Locations
🇦🇹

EBG MedAustron GmbH, Wiener Neustadt, Niederösterreich, Austria

© Copyright 2025. All Rights Reserved by MedPath